Advertisement

Topics

Companies Related to "Erlotinib Hydrochloride in Treating Patients With Previously Treated Non-Small Cell Lung Cancer, Head and Neck Cancer, or Esophageal Cancer and Precancerous Lesions of the Lung" [Most Relevant Company Matches] RSS

09:37 EST 14th December 2018 | BioPortfolio

Here are the most relevant search results for "Erlotinib Hydrochloride in Treating Patients With Previously Treated Non-Small Cell Lung Cancer, Head and Neck Cancer, or Esophageal Cancer and Precancerous Lesions of the Lung" found in our extensive corporate database of over 50,000 company records.

Showing "Erlotinib Hydrochloride Treating Patients With Previously Treated Small" Companies 1–25 of 5,700+

Relevant

Santarus, Inc. and Depomed, Inc.

Santarus, Inc. is a specialty biopharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by physician specialists. The company's current commercial efforts are focused on GLUMETZA® (metformin hydrochloride extended release tablets) and CYCLOSET® (bromocriptine mesylat...


Santarus, Inc. & Depomed, Inc.

Santarus, Inc. is a specialty biopharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by physician specialists. The company’s current commercial efforts are focused on GLUMETZA® (metformin hydrochloride extended release tablets) and CYCLOSET® (bromocriptine me...

OSI Pharmaceuticals

OSI Pharmaceuticals is committed to “shaping medicine and changing lives” by developing and commercializing high-quality and novel pharmaceutical products that extend life or improve the quality of life for patients with cancer, diabetes, and obesity. We specialize in the discovery and development of innovative molecular targeted therapies that address significant unmet medical needs, and st...


GelTex Incorporated

We are dedicated to having a positive effect on the lives of people living with illness and disease. We have demonstrated this by bringing important new therapies from discovery to market. GelTex’s first product, Renagel® brand sevelamer hydrochloride, was granted marketing approval by the U.S. Food and Drug Administration (FDA) in October 1998 for the reduction of serum phosphorus in hemodialy...

Hotze Health & Wellness Center

Hotze Health & Wellness Center, a part of Hotze Enterprises, is leading the revolution in wellness care by transforming the way patients are treated both internally and externally. Founded in 1989 by Steven F. Hotze, M.D., the Center has successfully treated nearly 20,000 patients. In an effort to help patients obtain and maintain life-long health and well...

Santarus, Inc.

Santarus, Inc. is a specialty biopharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by gastroenterologists, endocrinologists and other physicians. The company’s current commercial efforts are focused on GLUMETZA® (metformin HCl extended release tablets), which ...

Genetronics Biomedical

Genetronics' most advanced effort involves treating those with head and neck cancer, a particularly devastating cancer that can severely limit the ability of these patients to see, taste, hear, talk, breathe, or swallow. Genetronics received approval from the U.S. Food and Drug Administration and initiated Phase II multi-center clinical trials at nine sites in the U.S. The trials test the effectiv...

Senior Home Care, Inc.

Senior Home Care, Inc., through its divisions, Med Tech Services, Senior Home Care and Synergy Home Care, has been treating seniors throughout Florida and Louisiana with quality home health care services for more than 15 years. More than 50,000 seniors are treated each year with personalized home care programs created by their physician and certified nurse...

Synergy Home Care, Inc.

Senior Home Care, Inc., through its divisions, Med Tech Services, Senior Home Care and Synergy Home Care, has been treating seniors throughout Florida and Louisiana with quality home health care services for more than 15 years. More than 50,000 seniors are treated each year with personalized home care programs created by their physician and certified nurse...

The Moore Center

The Moore Center is the longest-established eating disorder treatment facility in Washington state and has been dedicated to treating patients with eating disorders for more than two decades. Founded in 1991 and located in Bellevue, The Moore Center is a regional referral center; providing specialized and comprehensive treatment for eating disorders. The m...

Medivation, Inc.

Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. In September 2008, Medivation announced a global agreement with Pfizer, Inc to develop an...

DACOGEN

DACOGEN is indicated for treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and secondary MDS of all French-American-British (FAB) subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia) and i...

TP Therapeutics Inc.

TP Therapeutics is a clinical-stage precision oncology company forging a new path for targeted cancer care. Founded in October 2013 by Dr. J. Jean Cui, the lead inventor of Pfizer’s oncology drugs crizotinib and lorlatinib, the company is developing a pipeline of novel drugs that aim to tackle treatment resistance and give new hope to patients who have ...

Cancer Vaccines Ltd

Cancer Vaccines Ltd is a biopharmaceutical company focused on the development and commercialisation of safe and effective therapeutic vaccines for the treatment of cancer. The company was founded in 1999 and won a DTI SMART Award.The attraction of a vaccination based approach to treating cancer is widely acknowledged, and many researchers and clinicians have worked in this area. Historically the a...

Thermocare, Inc

Our Patented Safe Heat design... ...provides the best possible environmental care for small animals, and aids in care management of your sick, recovering, or chronically ill small animals though the use of our Safe Heat design. I could not imagine practicing emergency and intensive care medicine without it! L.A. Bernstein V.M.D.Our products have been used by responsible veterinarians for over 2...

Contura Inc.

Aquamid is composed of 97.5% water for injection and 2.5% cross-linked polyacrylamide. The patented hydrogel is homogeneous: it contains no micro particles; hence its filling effect is due solely to the injected volume. Unlike particle-based fillers, the hydrogel does not rely on an intended foreign body reaction to achieve the desired augmentation. Therefore, the filling effect is immediate and p...

Turning Point Therapeutics, Inc.

Turning Point Therapeutics is a clinical-stage precision oncology company forging a new path for targeted cancer care. Founded in October 2013 by Dr. J. Jean Cui, the lead inventor of Pfizer’s oncology drugs crizotinib and lorlatinib, the company is developing a pipeline of novel drugs that aim to tackle treatment resistance and give new hope to patie...

Cortical Pty Ltd

Inflammatory diseases can be successfully targeted with anti-cytokine therapies. Small molecule cytokine antagonists have never previously been developed, but may provide a valuable combination of effectiveness in treatment, potential oral administration, and a cost which may allow more patients to receive the treatment. In addition such molecules have the potential for formulation for use as a to...

Thermedical

Based in Somerville, Mass., Thermedical is a privately held company founded by Michael G. Curley, Ph.D., and Patrick S. Hamilton, Ph.D. Under multiple National Institutes of Health (NIH) Small Business Innovation Research (SBIR) Grants and a Massachusetts Life Sciences Center Small Business Matching Grant (SBMG) Award, Thermedical is developing ther...

BIOCAD

Based in St. Petersburg, Russia, joint-stock company BIOCAD is a leading Russian private biopharmaceutical company, specializing in the research, development and manufacture of generic, biosimilar, and innovative drugs. BIOCAD works to provide more affordable therapeutic proteins and small-molecule generics to patients who previously had limited access to ...

GammaCan

GammaCan is a biopharmaceutical company focused on clinical-phase development and commercialization. GammaCan’s initial therapy under development is a first-in-class anti-cancer immunotherapy aimed at preventing metastasis (the spread of cancer to other parts of the body) of a variety of cancers. GammaCan’s first product was entered to phase-II clinical trials.GammaCan’s innovative treatment...

Miracor Medical Systems GmbH

Based in Vienna, Austria, privately held Miracor is commercializing a unique and potentially disruptive technology, PICSO®, for acute coronary syndrome (ACS), heart failure, and cardiac surgery patients. The Company’s objective is to establish PICSO® as the standard of care for heart attack patients, thereby improving their quality of life. The ...

Avexxin

Avexxin is a pharmaceutical company focused on developing and commercializing novel small molecule therapeutics for patients with chronic inflammatory conditions. Avexxin's advanced understanding of the biology of the inflammatory process has resulted in a novel therapeutic approach for the treatment of psoriasis and other inflammatory disorders. Our discovery and clinical development expertise is...

Genzyme

Genzyme is one of the world’s leading biotechnology companies. Its more than 9,000 employees work in countries throughout the world and are united by a common goal: to make a major positive impact on the lives of people with debilitating diseases. Since its founding in 1981, Genzyme has grown from a small start-up to a diversified enterprise with 2006 revenues of $3.2 billion. Over the past two...

BioStratum Incorporated

BioStratum is focused on the discovery, development and commercialization of novel therapeutic agents for the treatment of diabetes and diabetic complications. BioStratum's pipeline is led by Pyridorin™ a small molecule drug for the treatment of diabetic kidney disease, followed by pre-clinical compounds that will treat other diabetic complications and cancer. Pyridorin has been granted Fast Tra...


More From BioPortfolio on "Erlotinib Hydrochloride in Treating Patients With Previously Treated Non-Small Cell Lung Cancer, Head and Neck Cancer, or Esophageal Cancer and Precancerous Lesions of the Lung"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks